BamSEC and AlphaSense Join Forces
Learn More

Monte Rosa Therapeutics Inc.

NASDAQ: GLUE    
Share price (12/23/24): $7.14    
Market cap (12/23/24): $439 million

Material Contracts Filter

EX-10.1
from 10-Q 15 pages Second Amended and Restated Employment Agreement
12/34/56
EX-10.2
from 10-Q 67 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Information That Was Omitted Has Been Noted in This Document With a Placeholder Identified by the Mark “[***]”. Collaboration and License Agreement
12/34/56
EX-10.1
from 8-K 24 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 10-Q 10 pages August 9, 2023 Personal and Confidential Ajim Tamboli, Cfa Re: Separation Agreement Dear Ajim
12/34/56
EX-10.2
from 10-Q 8 pages Agreement for Termination of Lease Recitals
12/34/56
EX-10.22
from 10-K 20 pages Amended and Restated Employment Agreement
12/34/56
EX-10.21
from 10-K 20 pages Employment Agreement
12/34/56
EX-10.20
from 10-K 115 pages Lease by and Between B9 Ls Harrison & Washington LLC, a Delaware Limited Liability Company and Monte Rosa Therapeutics, Inc., a Delaware Corporation
12/34/56
EX-10.12
from S-1/A 16 pages Employment Agreement
12/34/56
EX-10.11
from S-1/A 15 pages 2.2. Group Structure
12/34/56
EX-10.10
from S-1/A 16 pages Employment Agreement
12/34/56
EX-10.9
from S-1/A 15 pages Employment Agreement
12/34/56
EX-10.8
from S-1/A 15 pages Employment Agreement
12/34/56
EX-10.7
from S-1/A 16 pages Employment Agreement
12/34/56
EX-10.3
from S-1/A 13 pages Monte Rosa Therapeutics, Inc. 2021 Employee Stock Purchase Plan
12/34/56
EX-10.2
from S-1/A 51 pages Monte Rosa Therapeutics, Inc. 2021 Stock Option and Incentive Plan
12/34/56
EX-10.19
from S-1 112 pages 645 Summer Street Boston, Ma Lease Agreement Between Opg Mp Parcel Owner (De) LLC, a Delaware Limited Liability Company, as Landlord and Monte Rosa Therapeutics, Inc., a Delaware Corporation, as Tenant Lease Agreement
12/34/56
EX-10.18
from S-1 65 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Information That Was Omitted Has Been Noted in This Document With a Placeholder Identified by the Mark “[***]”. Collaboration and Option Agreement (1) Cancer Research Technology Limited and (2) the Institute of Cancer Research and (3) Monte Rosa Therapeutics AG April 10, 2018
12/34/56
EX-10.17
from S-1 27 pages License Agreement (1) Cancer Research Technology Limited and (2) the Institute of Cancer Research and (3) Monte Rosa Therapeutics AG April 10, 2018
12/34/56
EX-10.16
from S-1 7 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Information That Was Omitted Has Been Noted in This Document With a Placeholder Identified by the Mark “[***]”. Services Agreement
12/34/56